TLR4 sensitizes plasmacytoid dendritic cells for antiviral response against SARS-CoV-2 coronavirus

King Hoo Lim1, Lishi Wang2, Eunice Dotse1

  • 1Department of Biomedical Sciences, City University of Hong Kong, 83 Tat Chee Ave, Kowloon Tong, Kowloon, Hong Kong.

Journal of Leukocyte Biology
|September 25, 2023
PubMed

Insights

Toll-like receptor 4 (TLR4) activates plasmacytoid dendritic cells similarly to TLR7/8, enhancing antiviral responses and type I interferon production against SARS-CoV-2. This reveals unique TLR4 activation pathways for therapeutic potential.

Area of Science:

  • Immunology
  • Cell Biology

Background:

  • Plasmacytoid dendritic cells (pDCs) are crucial for antiviral immunity, primarily via Toll-like receptor 7/8 (TLR7/8) stimulation.
  • The role of alternative Toll-like receptors (TLRs), such as TLR4, in pDC activation remains less understood compared to endosomal TLRs.

Purpose of the Study:

  • To investigate and compare pDC activation states induced by TLR4 stimulation versus canonical TLR7/8 stimulation.
  • To identify unique gene expression profiles and functional responses of pDCs under TLR4 activation.

Main Methods:

  • RNA sequencing was employed to analyze gene expression patterns in pDCs stimulated with TLR4 agonists.
  • Comparative analysis of gene expression between TLR4-activated pDCs, TLR7/8-activated pDCs, and conventional dendritic cells (cDCs).

Main Results:

  • TLR4 stimulation induced gene expression patterns highly similar to TLR7/8 stimulation in pDCs.
  • Unique genes were identified under TLR4 activation, and some genes showed higher induction magnitude compared to TLR7/8.
  • TLR4-activated pDCs exhibited distinct gene sets from cDCs, favoring infectious disease response over antigen presentation.
  • TLR4 activation sensitized pDCs against SARS-CoV-2 RNA by enhancing antiviral responses and type I interferon production.

Conclusions:

  • TLR4 activation represents a significant pathway for pDC activation, sharing similarities but also possessing unique characteristics compared to TLR7/8.
  • TLR4-mediated pDC activation enhances antiviral immunity, particularly against SARS-CoV-2, through type I interferon induction.
  • Understanding TLR4-driven pDC responses offers potential for novel therapeutic strategies in infectious diseases and other conditions.